Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.
Read original at benzingaStocks · News reference
8-K filing — Teladoc Health, Inc. (TDOC)
Filed: 2026-08-03 AccNo: 0001477449-26-000040 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 3, 2026, 8:31 PM
- Checked
- Aug 3, 2026, 8:31 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Teladoc Health shares are trading lower after Canaccord Genuity and Evercore ISI Group lowered their respective price targets on the stock.
Read original at benzingaStock Market Midday, July 30: Microsoft Soars 15%, Boosting Tech Stocks
Markets recovered from yesterday's losses with the Nasdaq up 2.42% as technology stocks rallied. Microsoft surged 15.5% following strong earnings results, boosting investor confidence in AI spending. However, GDP growth slowed to 1.5% in Q2, below expectations, signaling underlying economic uncertainty despite the market rebound.
Read original at the-motley-fool